News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Treatment of Gastroesophageal Junction Carcinoma

Ian Chau, MD, of Royal Marsden Hospital in London, reviews first- and second-line treatment options for patients with carcinoma of the gastroesophageal junction. In the first-line setting, different standards for treatment duration exist around the world, including the idea of relinking with the same chemotherapy if a patient achieves stable disease. In the second-line setting, Chau discusses the use of chemotherapy and ramucirumab.

Read Source
X